Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Kamat Speaks with ImmunityBio's Dr. Soon-Shiong

<< Previous

Bullboard Posts

Next >>

Comment by O12009on May 18, 2024 10:20am

181 Views

Post# 36047158

RE:Dr. Kamat Speaks with ImmunityBio's Dr. Soon-Shiong

Thanks for the post, very informative. In the part 2 Dr Patrick says they can continue to treat up to 37 months. So is this treatment an on going treatment like BCG and what happens if it is stopped at anytime. TLT treatment is one and done or if the cancer reoccurs they can treat again. This would be much easier for the patients and far less expensive for the medical system. Am I correct on that?

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia